2
NU673 Midterm PMHNP Exam with precise detailed answers || || || || || || ||
PMHNP role - ✔✔scholarly activities publishing lectures presentation preceptor ship continuing
|| || || || || || || || || || ||
education mentoring mutual respect client advocacy participate in ANA American psychiatric
|| || || || || || || || || || ||
nurse association international Society of psychiatric nurses health policy legal and ethical
|| || || || || || || || || || || ||
responsibility participate in government health policy activities case management risk assessment || || || || || || || || || || ||
for high risk situation risk management intervened to reduce risk of non-healthy behaviors and
|| || || || || || || || || || || || || ||
advance directives. ||
PMHNP scope of Practice - ✔✔ || || || || ||
Psychiatric H& P components - ✔✔Onset || || || || || ||
duration ||
characteristics ||
associated aggravating factors || || ||
relieving factors || ||
treatment and summary. || ||
Psychiatric Assessment - ✔✔establish therapeutic relationship of acceptance empathy || || || || || || || || ||
professionalism respect gather data review the purpose consider safety issues communication || || || || || || || || || || ||
skills screening tools developmental assessment differential diagnosis assess precipitating events
|| || || || || || || || || ||
stressors biological social psychological develop a treatment plan that safe based on evidence and
|| || || || || || || || || || || || || ||
culture competent must instill hope to decrease anxiety provide education and follow up labs and
|| || || || || || || || || || || || || || ||
referrals to neuropsych testing therapy education psychotropic meds reassurance follow up plan.
|| || || || || || || || || || ||
objective MSE scales in which examiner rates patient - ✔✔cooperative conversate without acute
|| || || || || || || || || || || || ||
distress orientation dress for agencies than cycle motor activity iContact euthymic affect fall even
|| || || || || || || || || || || || || ||
congruent with reported mood of speech is spontaneous normal rate appropriate volume and tone
|| || || || || || || || || || || || || ||
with no problems expressing self thought content is normal elicited content denies suicide denies
|| || || || || || || || || || || || || ||
homicidal process appears linear coherent goal directed cognition appears grossly intact with
|| || || || || || || || || || || ||
appropriate attention span and concentration and average fund of knowledge judgment appears
|| || || || || || || || || || || ||
fair insight appears fair the patient is able to articulate needs is motivated for compliance
|| || || || || || || || || || || || || || ||
,2
adherence to medication regime is willing and able to participate with treatment disposition and
|| || || || || || || || || || || || || ||
discharge planning. ||
Psychiatric Interview - ✔✔the most important element in the evaluation and care of persons with
|| || || || || || || || || || || || || || ||
mental illness ||
Psychiatric H&P - ✔✔ || || ||
psychiatric goals - ✔✔ || || ||
psychiatric treatment - ✔✔ || || ||
PMHNP mental health Anxiety assessment tools - ✔✔GAD-7:
|| || || || || || || ||
5-9 mild,
|| ||
10-14 mod, || ||
15-21 severe ||
HAM- A: || ||
14-17 mild, || ||
18-24 mod, || ||
25-30 severe ||
PMHNP depression rating tool - ✔✔HAM-D:
|| || || || || ||
0-7 norm,
|| ||
8-13 mild, || ||
14-18 mod, || ||
19-22 sv, || ||
23 severly severe
|| ||
, 2
PQH-9: ||
1-4 min,
|| ||
5-9 mild,
|| ||
10-14 mod, || ||
15-19 sev mod, >20 sv || || || ||
Beck Depression Inventory (BDI)
|| || ||
0-13 min depression
|| || ||
14-19 mild depression || || ||
20-28 mod depression || || ||
29-63 severe depression|| ||
Bipolar Spectrum Diagnostic Scale (BSDS) - ✔✔BSDS
|| || || || || ||
0-6 high unlike
|| || ||
7-12 low risk|| || ||
13-19 mod || ||
20-25 high likely || ||
social determinants of health - ✔✔The conditions in which people are born, grow, live, work, and
|| || || || || || || || || || || || || || || ||
age, shaped by the distribution of money, power, and resources at global, national, and local levels
|| || || || || || || || || || || || || || ||
Serotonin Syndrome - ✔✔With any drug that increases 5-HT (e.g., MAO inhibitors, SNRIs,
|| || || || || || || || || || || || ||
TCAs) hyperthermia, confusion, myoclonus, cardiovascular instability, flushing, diarrhea,
|| || || || || || || ||
seizures. A patient who presents with an excess of serotonin is likely experiencing serotonin
|| || || || || || || || || || || || || ||
syndrome. Serotonin syndrome is classified by restlessness, agitation, myoclonus, and vital sign
|| || || || || || || || || || || ||
abnormalities. Patients with a deficit of serotonin would present with depression, sleep || || || || || || || || || || || ||
dysregulation, and loss of appetite. || || || ||
-Treatment: cyproheptadine (5-HT2 receptor antagonist). || || || ||
NU673 Midterm PMHNP Exam with precise detailed answers || || || || || || ||
PMHNP role - ✔✔scholarly activities publishing lectures presentation preceptor ship continuing
|| || || || || || || || || || ||
education mentoring mutual respect client advocacy participate in ANA American psychiatric
|| || || || || || || || || || ||
nurse association international Society of psychiatric nurses health policy legal and ethical
|| || || || || || || || || || || ||
responsibility participate in government health policy activities case management risk assessment || || || || || || || || || || ||
for high risk situation risk management intervened to reduce risk of non-healthy behaviors and
|| || || || || || || || || || || || || ||
advance directives. ||
PMHNP scope of Practice - ✔✔ || || || || ||
Psychiatric H& P components - ✔✔Onset || || || || || ||
duration ||
characteristics ||
associated aggravating factors || || ||
relieving factors || ||
treatment and summary. || ||
Psychiatric Assessment - ✔✔establish therapeutic relationship of acceptance empathy || || || || || || || || ||
professionalism respect gather data review the purpose consider safety issues communication || || || || || || || || || || ||
skills screening tools developmental assessment differential diagnosis assess precipitating events
|| || || || || || || || || ||
stressors biological social psychological develop a treatment plan that safe based on evidence and
|| || || || || || || || || || || || || ||
culture competent must instill hope to decrease anxiety provide education and follow up labs and
|| || || || || || || || || || || || || || ||
referrals to neuropsych testing therapy education psychotropic meds reassurance follow up plan.
|| || || || || || || || || || ||
objective MSE scales in which examiner rates patient - ✔✔cooperative conversate without acute
|| || || || || || || || || || || || ||
distress orientation dress for agencies than cycle motor activity iContact euthymic affect fall even
|| || || || || || || || || || || || || ||
congruent with reported mood of speech is spontaneous normal rate appropriate volume and tone
|| || || || || || || || || || || || || ||
with no problems expressing self thought content is normal elicited content denies suicide denies
|| || || || || || || || || || || || || ||
homicidal process appears linear coherent goal directed cognition appears grossly intact with
|| || || || || || || || || || || ||
appropriate attention span and concentration and average fund of knowledge judgment appears
|| || || || || || || || || || || ||
fair insight appears fair the patient is able to articulate needs is motivated for compliance
|| || || || || || || || || || || || || || ||
,2
adherence to medication regime is willing and able to participate with treatment disposition and
|| || || || || || || || || || || || || ||
discharge planning. ||
Psychiatric Interview - ✔✔the most important element in the evaluation and care of persons with
|| || || || || || || || || || || || || || ||
mental illness ||
Psychiatric H&P - ✔✔ || || ||
psychiatric goals - ✔✔ || || ||
psychiatric treatment - ✔✔ || || ||
PMHNP mental health Anxiety assessment tools - ✔✔GAD-7:
|| || || || || || || ||
5-9 mild,
|| ||
10-14 mod, || ||
15-21 severe ||
HAM- A: || ||
14-17 mild, || ||
18-24 mod, || ||
25-30 severe ||
PMHNP depression rating tool - ✔✔HAM-D:
|| || || || || ||
0-7 norm,
|| ||
8-13 mild, || ||
14-18 mod, || ||
19-22 sv, || ||
23 severly severe
|| ||
, 2
PQH-9: ||
1-4 min,
|| ||
5-9 mild,
|| ||
10-14 mod, || ||
15-19 sev mod, >20 sv || || || ||
Beck Depression Inventory (BDI)
|| || ||
0-13 min depression
|| || ||
14-19 mild depression || || ||
20-28 mod depression || || ||
29-63 severe depression|| ||
Bipolar Spectrum Diagnostic Scale (BSDS) - ✔✔BSDS
|| || || || || ||
0-6 high unlike
|| || ||
7-12 low risk|| || ||
13-19 mod || ||
20-25 high likely || ||
social determinants of health - ✔✔The conditions in which people are born, grow, live, work, and
|| || || || || || || || || || || || || || || ||
age, shaped by the distribution of money, power, and resources at global, national, and local levels
|| || || || || || || || || || || || || || ||
Serotonin Syndrome - ✔✔With any drug that increases 5-HT (e.g., MAO inhibitors, SNRIs,
|| || || || || || || || || || || || ||
TCAs) hyperthermia, confusion, myoclonus, cardiovascular instability, flushing, diarrhea,
|| || || || || || || ||
seizures. A patient who presents with an excess of serotonin is likely experiencing serotonin
|| || || || || || || || || || || || || ||
syndrome. Serotonin syndrome is classified by restlessness, agitation, myoclonus, and vital sign
|| || || || || || || || || || || ||
abnormalities. Patients with a deficit of serotonin would present with depression, sleep || || || || || || || || || || || ||
dysregulation, and loss of appetite. || || || ||
-Treatment: cyproheptadine (5-HT2 receptor antagonist). || || || ||
